Mprila Tablet
By Mprila
Rx
10 Tablet in a Strip

Composition
Apremilast(30mg)

Manufacturer - Mylan Pharmaceuticals Pvt Ltd
Mylan Pharmaceuticals Private Limited , Commercial Operations , Prestige Tech Park,Platina-3, 7th to 12th floor, Prestige Tech Park, Kadubesanahalli, Bangalore -560103

Expires on or after
August, 2025

liver
Mprila Tablet is considered safe for use in patients with liver disease. It is not necessary to adjust the dosage of Mprila Tablet for individuals with liver issues. This means that patients with liver problems can generally take this medication without needing special considerations due to their liver condition. It is important to follow the prescribed dosage as instructed by your healthcare provider. Make sure to inform your doctor about any liver conditions you may have before starting Mprila Tablet to ensure proper monitoring and management of your health.

kidney
Mprila Tablet should be used cautiously in individuals with severe kidney disease. Dosage adjustment may be necessary, so it is important to seek advice from your healthcare provider.

alcohol
Caution is advised when consuming alcohol with Mprila Tablet. It is important to consult your doctor before drinking alcohol while taking this medication.

driving
When taking Mprila Tablet, it is uncertain if driving ability is affected. Avoid driving if you have symptoms that impact focus and reaction time.

pregnancy
Mprila Tablet is considered unsafe during pregnancy due to potential harmful effects on the developing baby. Limited human studies are available, but animal studies indicate this risk. Your doctor will assess the benefits and risks before prescribing. Consult your doctor regarding its use.

breastfeeding
It is better to consult your doctor before using Mprila Tablet.
Habit Forming | No |
Chemical Class | Isoindole Derivative |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹273
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024